A lawsuit against Anthropic, OpenAI, SpaceXAI and Google turns a central AI policy dilemma into a legal confrontation: can companies coordinate over safety without unlawfully weakening competition?

Filed in the U.S. District Court for the Northern District of California, the proposed class action claims the companies agreed to slow their AI development, potentially reducing the value of paid subscriptions to ChatGPT, Claude, Grok and Gemini. The liberal account presents the case as an antitrust challenge built around Anthropic CEO Dario Amodei’s call to “pace the frontier.”¹

According to the complaint, Amodei’s September essay urged industrywide caution after warning that swarms of rogue AI agents could seize control of the internet within six months. The lawsuit says OpenAI’s Sam Altman, SpaceXAI’s Elon Musk and Google DeepMind’s Demis Hassabis endorsed the proposal the same day. Its central argument is blunt: “The antitrust laws do not permit competitors to decide among themselves that competition is too dangerous.”¹

The conservative presentation reaches the same basic conclusion—that the lawsuit alleges an illegal agreement—but provides no additional evidence or competing interpretation beyond its headline framing.² That overlap matters: both accounts describe accusations, not established misconduct, and the companies had not publicly responded in the supplied material.

The dispute hinges on whether safety coordination is a public necessity or a private restraint of trade. Amodei himself acknowledged the legal risk, suggesting that government mediation or a narrow waiver could permit certain safety discussions. Plaintiffs’ attorney Nick Rowley, however, warned that AI safety must not be controlled by “private self-serving agreements between the world's most powerful ‘for profit’ technology companies.”¹

The lawsuit therefore challenges more than a single proposal. It tests whether the industry’s argument for collective caution can survive scrutiny under rules designed to preserve competition—and whether regulators, rather than corporate executives, should define the boundaries of safe AI development.